Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Rev. chil. endocrinol. diabetes ; 16(4): 130-133, 2023. tab
Article in Spanish | LILACS | ID: biblio-1512179

ABSTRACT

La tiroiditis subaguda (TSA) es un trastorno inflamatorio autolimitado de la glándula tiroides. Es más común en mujeres y se caracteriza por dolor cervical, síntomas inflamatorios sistémicos y disfunción tiroidea. La TSA se ha asociado a una infección viral previa, generalmente respiratoria o enteral. Múltiples virus se han relacionado con TSA. Desde mayo de 2020 se reportaron casos de TSA relacionados con la infección por SARS-CoV-2. Describimos 3 casos de SAT después de la vacuna COVID-19. Dos casos fueron inoculados con vacuna SARS-CoV-2 inactivada (CoronaVac) y uno con vacuna de ARNm Pfizer-BioNTech. Los síntomas clínicos comenzaron pocas semanas después de la inoculación. Presentaron dolor cervical anterior, fiebre, astenia y tirotoxicosis transitoria. En todos los casos la evolución fue favorable. Hasta donde sabemos, estos son los primeros casos de SAT posteriores a la vacuna COVID-19 descritos en Chile.


Subacute thyroiditis (SAT) is a self-limited inflammatory disorder of the thyroid gland. The disease is more common in women and is characterized by neck pain, systemic symptoms, and thyroid dysfunction. SAT It has been associated with viral, respiratory or enteral infection. Multiple viruses had been related to SAT. Since May 2020, cases of SAT related to SARS-CoV-2 infection were reported. We describe 3 cases of SAT following COVID-19 vaccine. Two cases were inoculated with inactivated SARS-CoV-2 vaccine (CoronaVac) and one with mRNA vaccine Pfizer­BioNTech. The clinical symptoms began few weeks after inoculation. They presented with neck pain, fever, general malaise and transient thyrotoxicosis. All cases revered spontaneously. To our knowledge, these are the first cases of SAT following COVID-19 vaccine described in Chile.


Subject(s)
Humans , Male , Female , Adult , Aged , Thyroiditis, Subacute/chemically induced , COVID-19 Vaccines/adverse effects , Vaccines, Inactivated/adverse effects , BNT162 Vaccine/adverse effects
2.
Rev. chil. infectol ; 31(6): 659-665, dic. 2014. tab
Article in Spanish | LILACS | ID: lil-734757

ABSTRACT

Introduction: By consensus severe, Clostridium difficile-associated infection (CDAI) is one that results in hospitalization in ICU, colectomy or death within 30 days. Multiple prognostic indices (IP) attempt to predict these adverse events. Objective: To evaluate the performance of 4 PI in predicting severe CDI. Methods: Hospitalized patients ≥ 18 years old with ICD were retrospectively evaluated. Patients with recurrent infection or hematological cancer were excluded. Four PI were evaluated: UPMC version 1, Calgary version 1, Hines VA and Calgary version 2. Results: Seven of 81 patients (8.1%) met the definition of severe CDI. Positive predicted value (PPV) and negative predicted value (NPV) of PI ranged from 20-75% and 91.3-95.7%, respectively. Only Hines VA index had a satisfactory Kappa index (0.74; 95% CI 0.41-1) with a PPV of 75% and NPV of 95,7%. However, because of the variables included, this PI could be calculated only in 32.6% of patients. Conclusion: Hines VA index has the best predicted value and agreement to rule out a severe CDI. Like others PI it has the limitation of including difficult variables to assess in all patients and tends to overestimate an unfavorable course.


Introducción: Por consenso, la infección asociada a Clostridium difficile (IACD) grave es aquella que resulta en hospitalización en unidad de cuidados intensivos, colectomía o muerte dentro de 30 días. Múltiples índices pronósticos (IP) intentan predecir estos eventos adversos. Objetivo: evaluar el rendimiento de cuatro IP en la predicción de IACD grave. Metodología: pacientes hospitalizados ≥ 18 años con IACD fueron evaluados retrospectivamente. Se excluyeron pacientes con infección recurrente o cáncer hematológico. Se evaluaron cuatro IP: UPMC versión 1, Calgary versión 1, Hines VA y Calgary versión 2. Resultados: Siete de 81 pacientes (8,1%) presentaron una IACD grave. El valor predictor positivo (VPP) y valor predictor negativo (VPN) de los IP varió entre 20-75% y 91,3-95,7%, respectivamente. Sólo el índice de Hines VA tuvo un índice Kappa satisfactorio (0,74;IC 95% 0,46-1) con un VPP de 75% y un VPN de 95,7%. Sin embargo, por las variables incluidas en este IP, sólo pudo ser calculado en 32,6% de los pacientes. Conclusión: El índice de Hines VA presenta el mejor valor predictor y concordancia para descartar una IACD grave. Como otros IP, tiene la limitación de incluir variables difícilmente evaluables en todos los pacientes y tiende a sobreestimar un curso desfavorable.


Subject(s)
Female , Humans , Male , Middle Aged , Clostridioides difficile , Clostridium Infections/mortality , Severity of Illness Index , Hospitals, University , Prognosis , Retrospective Studies
3.
Full dent. sci ; 4(14): 352-357, jan.-mar. 2013. ilus, tab, graf
Article in Portuguese | LILACS, BBO | ID: lil-681713

ABSTRACT

Os produtos de Musa paradisiaca (bananeira) são usados como sedativo para odontalgia, cicatrizante de feridas cirúrgicas de exodontia, úlcera gástrica, entre outras indicações em comunidades que têm por tradição o uso das plantas como Medicina alternativa. Na Endodontia, almeja-se uma medicação intracanal ideal contra cepas resistentes em infecções endodônticas refratárias. Por esse motivo, o objetivo desse trabalho foi testar a atividade antimicrobiana do extrato glicólico de Musa paradisiaca (Mp) sobre Enterococcus faecalis (Ef). Para realizar o experimento, o extrato glicólico de Musa paradisiaca (EGB) substituiu o Polietilenoglicol 400 (PEG), que é um veículo que compõe algumas medicações intracanal. Foi utilizado o teste de difusão em ágar, pelo método do poço, para a avaliação da atividade antimicrobiana contra a cepa de Ef, normalmente relacionada a infecções refratárias endodônticas. Experimento “A”: G1, PEG (controle negativo); G2, PEG e Ca(OH) 2 ; G3, EGB; G4, EGB e Ca(OH) 2 e G5, gel de clorexidina 2% (CHX – controle positivo). Experimento “B”: G1, PEG (controle negativo); G2, PEG e ZnO; G3, PEG, Ca(OH) 2 e ZnO; G4, EGB e ZnO; G5, EGB, Ca(OH) 2 e ZnO e G6, CHX (controle positivo). Apenas a pasta de EGB e ZnO obteve atividade antimicrobiana estatisticamente significante, podendo ser uma propriedade importante para a composição de medicação intracanal. Todo novo biomaterial baseado na etnobotânica deve ser testado criteriosamente para viabilizar sua aplicabilidade clínica, o que justificou a pertinência deste estudo preliminar. No entanto, testes físico-químicos e de biocompatibilidade são imprescindíveis para futuro emprego de fitoterápicos na Endodontia


The products of Musa paradisiaca (banana plantain) are used as a sedative for dental pain, healing of tooth extraction surgical wounds, gastric ulcer, among other indications in communities that have the tradition of using plants as alternative Medicine. Endodontics searchs for an ideal intracanal medication for resistant strains on refractory endodontic infections. Therefore, the objective of this study was to test the antimicrobial activity of Musa paradisiaca (Mp) glycolic extract over Enterococcus faecalis (Ef). To perform the experiment, the Polyethyleneglycol 400 (PEG), used to make some intracanal medication, was replaced by Musa paradisiaca glycolic extract. Agar well diffusion test was used to evaluate antimicrobial activity over Ef. Strains normally related to refractory endodontic infections. Experiment “A”: G1, PEG (negative control); G2, PEG and Ca(OH)2; G3, EGB; G4, EGB and Ca(OH)2; and G5, 2% chlorhexidine gel (CHX - positive control). Experiment “B”: G1, PEG (negative control); G2, PEG and ZnO; G3, PEG, Ca(OH)2 and ZnO; G4, ZnO and EGB; G5, EGB, Ca(OH)2 and ZnO; and G6, CHX (positive control). Only the EGB and ZnO paste has obtained statistically significant antimicrobial activity, indicating that it can be an important property for a new intracanal medication. Every new biomaterial based on ethnobotanic should be carefully tested to allow its clinical applicability reinforcing the relevance of this preliminary study. However, physicochemical and biocompatibility tests are essential to future utilization of herbal medicines in Endodontics


Subject(s)
Endodontics/methods , In Vitro Techniques , Musa , Plants, Medicinal , Products with Antimicrobial Action , Pharmaceutical Preparations/administration & dosage
4.
Arch. oral res. (Impr.) ; 7(2): 157-160, Mayo-Aug. 2011. tab
Article in English | LILACS, BBO | ID: lil-667664

ABSTRACT

Objective: The aim of this study was to determine the correlation between the diameter D0 of guttapercha points from three different commercial brands (Tanari Man, Cone Tech and Dentsply) and their original respective values. Materials and methods: A high precision micrometer was used by a single calibrated operator to evaluate if the gutta-percha points are in aggrement with the n. 57 ANSI/ADA specification. Results: For the 0.04 tapered points, Cone Tech showed lower percentage of inadequate points (52%), followed by Dentsply (56%) and Tanari (80%). For the 0.06 tapered points, Cone Tech showed lower percentage of inadequate points (50%), followed by manufacturers Dentsply (53%) and Tanari (81%). Conclusions: It can be concluded that there is no standardization in the diameter D0 of the gutta-percha points of different commercial brands.


Objetivo: O objetivo deste estudo foi determinar a correlação entre o diâmetro D0 dos cones de guta-percha detrês diferentes marcas comerciais (Tanari Man, Cone Tech e Dentsply) com seus respectivos valores originais. Materiais e métodos: Um micrômetro de alta precisão foi utilizado por um único operador devidamente calibradopara avaliar se os cones de guta-percha estavam de acordo com a norma n. 57 da ANSI/ADA. Resultados:Para a conicidade 0.04, Cone Tech apresentou menor percentual de cones inadequados (52%), seguido deDentsply (56%) e Tanari (80%). Para a conicidade 0.06, Cone Tech apresentou menor percentual de conesinadequados (50%), seguido de Dentsply (53%) e Tanari (81%). Conclusões: Pôde-se concluir que não há padronizaçãono diâmetro D0 dos cones de guta-percha das diferentes marcas comerciais.


Subject(s)
Humans , Gutta-Percha/chemistry , Root Canal Filling Materials/chemistry , Dental Instruments , Gutta-Percha/standards , Materials Testing , Reference Values
5.
Braz. dent. j ; 21(4): 301-304, 2010. graf, tab
Article in English | LILACS | ID: lil-562089

ABSTRACT

This study evaluated the dimensional alterations and the solubility of two experimental endodontic sealers based on Copaifera multijuga oil-resin (Biosealer) and castor oil bean cement (Poliquil), maintained in different storage solutions. Twenty specimens (3 mm diameter and 2 mm height) of each sealer were assigned to 2 groups (n=10) according to the storage solution: simulated tissue fluid (STF) or distilled water (DW). The specimens were stored in these solutions during 90 days, being removed every 30 days for weighting. The solutions were renewed every 15 days. The results were subjected to statistical analysis by Dunn's and Mann-Whitney tests (a=0.05). The solubility of Poliquil was higher in STF (38.4 ± 36.0) than in DW (28.4 ± 15.0), while Biosealer showed higher solubility in DW (34.61 ± 6.0) than in STF (18.59 ± 8.0). The storage solution influenced the behavior of sealers in relation to the weight variation (p=0.0001). Poliquil presented higher variation of weight independent of the solution (p=0.239). Biosealer also presented higher variation of weight regardless of the solution (p=0.0001). The solubility of Biosealer was different from that of Poliquil, but both sealers showed low solubility in STF. Under the tested conditions, neither of the materials were according to the ADA'S specification.


O presente estudo avaliou a alteração dimensional e solubilidade de 2 cimentos experimentais (à base de resina do óleo de Copaíba - Biosealer e cimento do polímero da mamona - Poliquil), mantidos em diferentes meios de armazenamento. Foram confeccionados 20 espécimes de cada cimento com 3 mm de diâmetro e 2 mm de altura os quais foram divididos em 2 grupos (n=10) de acordo com o meio de armazenamento (fluido tissular simulado ou água destilada). Os espécimes foram atidos nas soluções durante 90 dias, sendo removidos a cada 30 dias para pesagem das amostras, no entanto as soluções foram trocadas a cada 15 dias. Os resultados foram submetidos aos testes de Dunn (5 por cento) e Mann-Whitney. Os meios de armazenamento causaram influência no comportamento dos cimentos em relação ao peso (p=0,0001). Poliquil apresentou alta variação de peso independente da solução (p=0,239). Biosealer também apresentou alta variação de peso independente da solução (p=0,0001). A solubilidade do Biosealer foi diferente do Poliquil, entretanto, ambos cimentos mostraram baixa solubilidade no fluido tissular simulado. Nas condições do experimento, nenhum cimento está de acordo com a especificação da ADA.


Subject(s)
Dental Cements/chemistry , Plant Oils/chemistry , Resins, Plant/chemistry , Root Canal Filling Materials/chemistry , Ricinus communis , Dental Marginal Adaptation , Dental Leakage/prevention & control , Fabaceae , Materials Testing , Solubility , Statistics, Nonparametric , Time Factors
6.
In. Caicedo T., Wilso; Franco F., Rubén; Ramos, Edison; Riofrío, Mario. Feocromocitoma, presentación de 2 casos. s.l, s.n, s.f. p.16, graf, tab.
Non-conventional in Spanish | LILACS | ID: lil-297058

ABSTRACT

La Tb. pulmonar es una enfermedad infecciosa crónica; aunque la tuberculosis tiene tratamiento desde la década de los setenta, sigue representando una alta tasa de morbimortalidad a nivel mundial. Se realizó un estudio de los casosm de tuberculosis en el Cantón Pedro Moncayo que cuenta con una población estimada de 18043 habitantes para 1998, la zona rural marginal cuenta con altos índices de pobreza, malnutrición, hacinamiento y falta de atención sanitaria. Se encontró 19 casos de tuberculosis pulmonar desde 1991 a 1998, de los cuales el 52,6 por ciento fueron mujeres con una media edad de 42,3 años, y un 47,4 por ciento de hombres con una media edad de 33 años; el síntoma más frecuente fue la tos de larga evolución...


Subject(s)
Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/therapy
SELECTION OF CITATIONS
SEARCH DETAIL